BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this clinical trial is to compare in a double-blind randomized trial,
the efficacy and safety of ciprofloxacin MR 1000 mg tablets given as a single-dose or as a
multiple-dose regimen for the prevention of infectious complications in patients undergoing
transrectal needle biopsies of the prostate (TRNBP).